Los puntos clave no están disponibles para este artículo en este momento.
These findings suggest that the potential of sevoflurane in protecting the lungs donated after cardiac death and reconditioned using EVLP could improve the outcome of these lungs following subsequent transplantation.
Wang et al. (Thu,) studied this question.